Drug Type Monoclonal antibody |
Synonyms LQ016 |
Target |
Action inhibitors |
Mechanism Ang2 inhibitors(Angiopoietin-2 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dystrophy, Macular | Preclinical | China | 24 Aug 2022 |